Last reviewed · How we verify

Stimulant or sedative

University of Illinois at Chicago · FDA-approved active Small molecule ✓ Verified May 2026 Quality 5/100

Stimulant or sedative is a Small molecule drug developed by University of Illinois at Chicago. It is currently FDA-approved.

Dextromethorphan has been studied as a potential treatment for postoperative pain, particularly in children undergoing tonsillectomy. It has also been investigated for its effects on pain in other conditions, including trauma and substance-related disorders.

At a glance

Generic nameStimulant or sedative
SponsorUniversity of Illinois at Chicago
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Stimulant or sedative

What is Stimulant or sedative?

Stimulant or sedative is a Small molecule drug developed by University of Illinois at Chicago.

Who makes Stimulant or sedative?

Stimulant or sedative is developed and marketed by University of Illinois at Chicago (see full University of Illinois at Chicago pipeline at /company/university-of-illinois-at-chicago).

What development phase is Stimulant or sedative in?

Stimulant or sedative is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing